Dyspepsia and GERD: breaking the rules
- PMID: 15984969
- DOI: 10.1111/j.1572-0241.2005.50317.x
Dyspepsia and GERD: breaking the rules
Abstract
Dyspepsia is a common condition in clinical practice. Economic models have suggested that empirical PPI therapy may be cost-effective in uninvestigated dyspepsia. Empirical PPI therapy is an attractive alternative to endoscopic investigation in young dyspeptic patients who are not infected with Helicobacter pylori.
Comment on
-
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.Am J Gastroenterol. 2005 Jul;100(7):1477-88. doi: 10.1111/j.1572-0241.2005.40280.x. Am J Gastroenterol. 2005. PMID: 15984968 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical